{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:26:02Z","timestamp":1787570762319,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["2254093"],"award-info":[{"award-number":["2254093"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52273118, 22275013"],"award-info":[{"award-number":["52273118, 22275013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04670-1","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:39:16Z","timestamp":1781527156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Zn2+\/Ca2+ co-overloaded nano-modulator amplifies reactive oxygen species to potentiate shikonin-induced necroptosis against triple\u2011negative breast cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Jingxia","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"4670_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"The Cancer Genome Atlas Network","year":"2012","unstructured":"The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61\u201370. https:\/\/doi.org\/10.1038\/nature11412.","journal-title":"Nature"},{"key":"4670_CR2","doi-asserted-by":"publisher","first-page":"e70013","DOI":"10.1002\/mef2.70013","volume":"4","author":"Z Huang","year":"2025","unstructured":"Huang Z, Peng Q, Mao L, Ouyang W, Xiong Y, Tan Y, et al. Neoadjuvant strategies for triple negative breast cancer: current evidence and future perspectives. Medcomm \u2013 Future Med. 2025;4:e70013. https:\/\/doi.org\/10.1002\/mef2.70013.","journal-title":"Medcomm \u2013 Future Med"},{"key":"4670_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13045-023-01497-3","volume":"16","author":"S Zhu","year":"2023","unstructured":"Zhu S, Wu Y, Song B, Yi M, Yan Y, Mei Q, et al. Recent advances in targeted strategies for triple-negative breast cancer. J Hematol Oncol. 2023;16:100. https:\/\/doi.org\/10.1186\/s13045-023-01497-3.","journal-title":"J Hematol Oncol"},{"key":"4670_CR4","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1158\/0008-5472.CAN-12-1527","volume":"72","author":"S Singh","year":"2012","unstructured":"Singh S, Sharma A, Robertson GP. Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns. Cancer Res. 2012;72:5663\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-1527.","journal-title":"Cancer Res"},{"key":"4670_CR5","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med Nat Publishing Group. 2025;31:1154\u201362. https:\/\/doi.org\/10.1038\/s41591-025-03502-3.","journal-title":"Nat Med Nat Publishing Group"},{"key":"4670_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13:674\u201390. https:\/\/doi.org\/10.1038\/nrclinonc.2016.66.","journal-title":"Nat Rev Clin Oncol"},{"key":"4670_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/imm.13793","volume":"173","author":"Z-B Wang","year":"2024","unstructured":"Wang Z-B, Zhang X, Fang C, Liu X-T, Liao Q-J, Wu N, et al. Immunotherapy and the ovarian cancer microenvironment: exploring potential strategies for enhanced treatment efficacy. Immunology. 2024;173:14\u201332. https:\/\/doi.org\/10.1111\/imm.13793.","journal-title":"Immunology"},{"key":"4670_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2020.10.016","volume":"497","author":"X Bai","year":"2021","unstructured":"Bai X, Ni J, Beretov J, Graham P, Li Y. Triple-negative breast cancer therapeutic resistance: where is the achilles\u2019 heel? Cancer Lett. 2021;497:100\u201311. https:\/\/doi.org\/10.1016\/j.canlet.2020.10.016.","journal-title":"Cancer Lett"},{"key":"4670_CR9","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3390\/cancers16101791","volume":"16","author":"M Kesireddy","year":"2024","unstructured":"Kesireddy M, Elsayed L, Shostrom VK, Agarwal P, Asif S, Yellala A, et al. Overall survival and prognostic factors in metastatic triple-negative breast cancer: a national cancer database analysis. Cancers Multidisciplinary Digit Publishing Inst. 2024;16:1791. https:\/\/doi.org\/10.3390\/cancers16101791.","journal-title":"Cancers Multidisciplinary Digit Publishing Inst"},{"key":"4670_CR10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.cell.2018.03.041","volume":"173","author":"C Kim","year":"2018","unstructured":"Kim C, Gao R, Sei E, Brandt R, Hartman J, Hatschek T, et al. Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing. Cell. 2018;173:879\u2013e89313. https:\/\/doi.org\/10.1016\/j.cell.2018.03.041.","journal-title":"Cell"},{"key":"4670_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/BCTT.S348060","volume":"14","author":"M Maqbool","year":"2022","unstructured":"Maqbool M, Bekele F, Fekadu G. Treatment strategies against triple-negative breast cancer: an updated review. Breast Cancer: Targets Ther. 2022;14:15\u201324. https:\/\/doi.org\/10.2147\/BCTT.S348060.","journal-title":"Breast Cancer: Targets Ther"},{"key":"4670_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7:196. https:\/\/doi.org\/10.1038\/s41392-022-01046-3.","journal-title":"Signal Transduct Target Ther"},{"key":"4670_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15:174. https:\/\/doi.org\/10.1186\/s13045-022-01392-3.","journal-title":"J Hematol Oncol"},{"key":"4670_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12951-025-03229-w","volume":"23","author":"X Hu","year":"2025","unstructured":"Hu X, Zhu H, Shen Y, Rao L, Li J, He X, et al. Metal-organic framework nanoparticles activate cGAS-STING pathway to improve radiotherapy sensitivity. J Nanobiotechnol. 2025;23:131. https:\/\/doi.org\/10.1186\/s12951-025-03229-w.","journal-title":"J Nanobiotechnol"},{"key":"4670_CR15","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1038\/s41467-025-58158-x","volume":"16","author":"M Aine","year":"2025","unstructured":"Aine M, Nacer DF, Arbajian E, Veerla S, Karlsson A, H\u00e4kkinen J, et al. The DNA methylation landscape of primary triple-negative breast cancer. Nat Commun. 2025;16:3041. https:\/\/doi.org\/10.1038\/s41467-025-58158-x.","journal-title":"Nat Commun"},{"key":"4670_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.trecan.2017.03.002","volume":"3","author":"A Najafov","year":"2017","unstructured":"Najafov A, Chen H, Yuan J. Necroptosis and cancer. Trends Cancer. 2017;3:294\u2013301. https:\/\/doi.org\/10.1016\/j.trecan.2017.03.002.","journal-title":"Trends Cancer"},{"key":"4670_CR17","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1016\/j.apsb.2023.05.018","volume":"13","author":"Q Liu","year":"2023","unstructured":"Liu Q, Zou J, Chen Z, He W, Wu W. Current research trends of nanomedicines. Acta Pharm Sin B. 2023;13:4391\u2013416. https:\/\/doi.org\/10.1016\/j.apsb.2023.05.018.","journal-title":"Acta Pharm Sin B"},{"key":"4670_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jare.2018.06.005","volume":"15","author":"S Hossen","year":"2019","unstructured":"Hossen S, Hossain MK, Basher MK, Mia MNH, Rahman MT, Uddin MJ. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: a review. J Adv Res. 2019;15:1\u201318. https:\/\/doi.org\/10.1016\/j.jare.2018.06.005.","journal-title":"J Adv Res"},{"key":"4670_CR19","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.7150\/thno.103636","volume":"15","author":"X Shao","year":"2025","unstructured":"Shao X, Zhao X, Wang B, Fan J, Wang J, An H. Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy. Theranostics. 2025;15:1689\u2013714. https:\/\/doi.org\/10.7150\/thno.103636.","journal-title":"Theranostics"},{"key":"4670_CR20","doi-asserted-by":"publisher","first-page":"113775","DOI":"10.1016\/j.jconrel.2025.113775","volume":"383","author":"H Nam","year":"2025","unstructured":"Nam H, Park H, Son MK, Kang I, Choi Y, Lee S, et al. Metal-phenolic networks reverse the immunosuppressive tumor microenvironment via dual metabolism regulation and immunogenic cell death. J Controlled Release. 2025;383:113775. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113775.","journal-title":"J Controlled Release"},{"key":"4670_CR21","doi-asserted-by":"publisher","first-page":"e23478","DOI":"10.1002\/adfm.202523478","volume":"36","author":"TMH Huynh","year":"2026","unstructured":"Huynh TMH, Tran N-T, Lee Y-S, Chang Y-H, Iao HM, Pan W-C, et al. Dysfunctional T cell reprogramming via cascade-responsive catalytic nanosponges-mediated tumor-specific antigen capture for remote glioblastoma immunotherapy. Adv Funct Mater. 2026;36:e23478. https:\/\/doi.org\/10.1002\/adfm.202523478.","journal-title":"Adv Funct Mater"},{"key":"4670_CR22","doi-asserted-by":"publisher","first-page":"25134","DOI":"10.1021\/acsnano.5c05395","volume":"19","author":"TMH Huynh","year":"2025","unstructured":"Huynh TMH, Huang P-X, Wang K-L, Tran N-T, Iao HM, Pan W-C, et al. Reprogramming immunodeficiency in lung metastases via PD-L1 siRNA delivery and antigen capture of nanosponge-mediated dendritic cell modulation. ACS Nano. 2025;19:25134\u201353. https:\/\/doi.org\/10.1021\/acsnano.5c05395.","journal-title":"ACS Nano"},{"key":"4670_CR23","doi-asserted-by":"publisher","first-page":"e202211254","DOI":"10.1002\/anie.202211254","volume":"61","author":"Y Ju","year":"2022","unstructured":"Ju Y, Zhao Y, Guan Q, Yang S, Wang W, Yan B, et al. Amorphous calcium carbonate cluster nanospheres in water-deficient organic solvents. Angew Chem Int Ed. 2022;61:e202211254. https:\/\/doi.org\/10.1002\/anie.202211254.","journal-title":"Angew Chem Int Ed"},{"key":"4670_CR24","doi-asserted-by":"publisher","first-page":"7883","DOI":"10.1039\/D1CS00519G","volume":"51","author":"Y-Q Niu","year":"2022","unstructured":"Niu Y-Q, Liu J-H, Aymonier C, Fermani S, Kralj D, Falini G, et al. Calcium carbonate: controlled synthesis, surface functionalization, and nanostructured materials. Chem Soc Rev. 2022;51:7883\u2013943. https:\/\/doi.org\/10.1039\/D1CS00519G.","journal-title":"Chem Soc Rev"},{"key":"4670_CR25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.apsb.2023.08.027","volume":"14","author":"H Liu","year":"2024","unstructured":"Liu H, Wen Z, Liu Z, Yang Y, Wang H, Xia X, et al. Unlocking the potential of amorphous calcium carbonate: a star ascending in the realm of biomedical application. Acta Pharm Sin B. 2024;14:602\u201322. https:\/\/doi.org\/10.1016\/j.apsb.2023.08.027.","journal-title":"Acta Pharm Sin B"},{"key":"4670_CR26","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.1021\/acsnano.3c10173","volume":"18","author":"Z Guo","year":"2024","unstructured":"Guo Z, Gao X, Lu J, Li Y, Jin Z, Fahad A, et al. Apoptosis and paraptosis induced by disulfiram-loaded Ca2+ \/Cu2+ dual-ions nano trap for breast cancer treatment. ACS Nano. 2024;18:6975\u201389. https:\/\/doi.org\/10.1021\/acsnano.3c10173.","journal-title":"ACS Nano"},{"key":"4670_CR27","doi-asserted-by":"publisher","first-page":"eaax1346","DOI":"10.1126\/sciadv.aax1346","volume":"6","author":"C-C Xue","year":"2020","unstructured":"Xue C-C, Li M-H, Zhao Y, Zhou J, Hu Y, Cai K-Y, et al. Tumor microenvironment-activatable Fe-doxorubicin preloaded amorphous CaCO3 nanoformulation triggers ferroptosis in target tumor cells. Sci Adv. 2020;6:eaax1346. https:\/\/doi.org\/10.1126\/sciadv.aax1346.","journal-title":"Sci Adv"},{"key":"4670_CR28","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1021\/acs.cgd.6b00630","volume":"16","author":"DJ Tobler","year":"2016","unstructured":"Tobler DJ, Rodriguez Blanco JD, S\u00f8rensen HO, Stipp SLS, Dideriksen K. Effect of pH on amorphous calcium carbonate structure and transformation. Cryst Growth Des. 2016;16:4500\u20138. https:\/\/doi.org\/10.1021\/acs.cgd.6b00630.","journal-title":"Cryst Growth Des"},{"key":"4670_CR29","doi-asserted-by":"publisher","unstructured":"Yang Y, Karakhanova S, Hartwig W, D\u2019Haese JG, Philippov PP, Werner J et al. Mitochondria and mitochondrial ROS in cancer: novel targets for anticancer therapy. J Cell Physiol. 2016;231:2571\u201381. https:\/\/doi.org\/10.1002\/jcp.25349","DOI":"10.1002\/jcp.25349"},{"key":"4670_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/anie.201710910","volume":"57","author":"K Laws","year":"2018","unstructured":"Laws K, Bineva-Todd G, Eskandari A, Lu C, O\u2019Reilly N, Suntharalingam K. A copper(II) phenanthroline metallopeptide that targets and disrupts mitochondrial function in breast cancer stem cells. Angew Chem Int Ed. 2018;57:287\u201391. https:\/\/doi.org\/10.1002\/anie.201710910.","journal-title":"Angew Chem Int Ed"},{"key":"4670_CR31","doi-asserted-by":"publisher","first-page":"2501721","DOI":"10.1002\/smll.202501721","volume":"21","author":"R Jiang","year":"2025","unstructured":"Jiang R, Rao J, Su H, Li M. Degradable metal-small molecule drug coordination nanomedicines for DNA damage-augmented cancer chemodynamic therapy. Small. 2025;21:2501721. https:\/\/doi.org\/10.1002\/smll.202501721.","journal-title":"Small"},{"key":"4670_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/cells10010130","volume":"10","author":"M Kielbik","year":"2021","unstructured":"Kielbik M, Szulc-Kielbik I, Klink M. Calreticulin\u2014multifunctional chaperone in immunogenic cell death: potential significance as a prognostic biomarker in ovarian cancer patients. Cells. 2021;10:130\u201352. https:\/\/doi.org\/10.3390\/cells10010130.","journal-title":"Cells"},{"key":"4670_CR33","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1038\/s41467-018-06807-9","volume":"9","author":"DV Krysko","year":"2018","unstructured":"Krysko DV, Ravichandran KS, Vandenabeele P. Macrophages regulate the clearance of living cells by calreticulin. Nat Commun. 2018;9:4644. https:\/\/doi.org\/10.1038\/s41467-018-06807-9.","journal-title":"Nat Commun"},{"key":"4670_CR34","doi-asserted-by":"publisher","first-page":"e09685","DOI":"10.1002\/smll.202509685","volume":"21","author":"J Chen","year":"2025","unstructured":"Chen J, Fei S, Cao Z, Liu X, Ji W, Chen H, et al. Tumor microenvironment metabolism-modulating nanomedicines for enhancing anti-tumor immunity. Small. 2025;21:e09685. https:\/\/doi.org\/10.1002\/smll.202509685.","journal-title":"Small"},{"key":"4670_CR35","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1084\/jem.20110251","volume":"208","author":"IL Ch\u2019","year":"2011","unstructured":"Ch\u2019 IL, Tsau JS, Molkentin JD, Komatsu M, Hedrick SM. Mechanisms of necroptosis in T cells. J Exp Med. 2011;208:633\u201341. https:\/\/doi.org\/10.1084\/jem.20110251.","journal-title":"J Exp Med"},{"key":"4670_CR36","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.molcel.2023.12.041","volume":"84","author":"S Hou","year":"2024","unstructured":"Hou S, Zhang J, Jiang X, Yang Y, Shan B, Zhang M, et al. PARP5A and RNF146 phase separation restrains RIPK1-dependent necroptosis. Mol Cell. 2024;84:938\u2013e9548. https:\/\/doi.org\/10.1016\/j.molcel.2023.12.041.","journal-title":"Mol Cell"},{"key":"4670_CR37","doi-asserted-by":"publisher","first-page":"e2507028122","DOI":"10.1073\/pnas.2507028122","volume":"122","author":"Y Ma","year":"2025","unstructured":"Ma Y, Zhang Q, Li D, Zhao K, Li Z, Liu Y, et al. Intercellular propagation of RIPK1\/RIPK3 amyloid fibrils. Proc Natl Acad Sci. 2025;122:e2507028122. https:\/\/doi.org\/10.1073\/pnas.2507028122.","journal-title":"Proc Natl Acad Sci"},{"key":"4670_CR38","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1158\/1535-7163.MCT-06-0511","volume":"6","author":"W Han","year":"2007","unstructured":"Han W, Li L, Qiu S, Lu Q, Pan Q, Gu Y, et al. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther. 2007;6:1641\u20139. https:\/\/doi.org\/10.1158\/1535-7163.MCT-06-0511.","journal-title":"Mol Cancer Ther"},{"key":"4670_CR39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","volume":"26","author":"A Murao","year":"2021","unstructured":"Murao A, Aziz M, Wang H, Brenner M, Wang P. Release mechanisms of major DAMPs. Apoptosis. 2021;26:152\u201362. https:\/\/doi.org\/10.1007\/s10495-021-01663-3.","journal-title":"Apoptosis"},{"key":"4670_CR40","doi-asserted-by":"publisher","first-page":"23189","DOI":"10.1074\/jbc.M114.567107","volume":"289","author":"Q Cao","year":"2014","unstructured":"Cao Q, Zhao K, Zhong XZ, Zou Y, Yu H, Huang P, et al. SLC17A9 protein functions as a lysosomal ATP transporter and regulates cell viability. J Biol Chem. 2014;289:23189\u201399. https:\/\/doi.org\/10.1074\/jbc.M114.567107.","journal-title":"J Biol Chem"},{"key":"4670_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2024.09.005","volume":"106\u2013107","author":"F Chen","year":"2024","unstructured":"Chen F, Tang H, Cai X, Lin J, Kang R, Tang D, et al. DAMPs in immunosenescence and cancer. Semin Cancer Biol. 2024;106\u2013107:123\u201342. https:\/\/doi.org\/10.1016\/j.semcancer.2024.09.005.","journal-title":"Semin Cancer Biol"},{"key":"4670_CR42","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","volume":"575","author":"M Fritsch","year":"2019","unstructured":"Fritsch M, G\u00fcnther SD, Schwarzer R, Albert M-C, Schorn F, Werthenbach JP, et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature. 2019;575:683\u20137. https:\/\/doi.org\/10.1038\/s41586-019-1770-6.","journal-title":"Nature"},{"key":"4670_CR43","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18:1106\u201321. https:\/\/doi.org\/10.1038\/s41423-020-00630-3.","journal-title":"Cell Mol Immunol"},{"key":"4670_CR44","doi-asserted-by":"publisher","first-page":"10760","DOI":"10.3390\/ijms251910760","volume":"25","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Zhang F, Xie W, Niu Y, Wang H, Li G, et al. Induced necroptosis and its role in cancer immunotherapy. Int J Mol Sci. 2024;25:10760. https:\/\/doi.org\/10.3390\/ijms251910760.","journal-title":"Int J Mol Sci"},{"key":"4670_CR45","doi-asserted-by":"publisher","first-page":"119126","DOI":"10.1016\/j.jep.2024.119126","volume":"338","author":"J Zhou","year":"2025","unstructured":"Zhou J, Guo Z, Peng X, Wu B, Meng Q, Lu X, et al. Chrysotoxine regulates ferroptosis and the PI3K\/AKT\/mTOR pathway to prevent cervical cancer. J Ethnopharmacol. 2025;338:119126. https:\/\/doi.org\/10.1016\/j.jep.2024.119126.","journal-title":"J Ethnopharmacol"},{"key":"4670_CR46","doi-asserted-by":"publisher","first-page":"1603093","DOI":"10.3389\/fphar.2025.1603093","volume":"16","author":"W Liu","year":"2025","unstructured":"Liu W, Liu Q, Yao J, Wu D, Li W, Fu Z, et al. Systematic bioinformatics analysis identifies shikonin as a novel mTOR pathway inhibitor in triple-negative breast cancer progression. Front Pharmacol. 2025;16:1603093. https:\/\/doi.org\/10.3389\/fphar.2025.1603093.","journal-title":"Front Pharmacol"},{"key":"4670_CR47","doi-asserted-by":"publisher","first-page":"11398","DOI":"10.3390\/ijms222111398","volume":"22","author":"AO Babamale","year":"2021","unstructured":"Babamale AO, Chen S-T. Nod-like receptors: critical intracellular sensors for host protection and cell death in microbial and parasitic infections. Int J Mol Sci. 2021;22:11398. https:\/\/doi.org\/10.3390\/ijms222111398.","journal-title":"Int J Mol Sci"},{"key":"4670_CR48","doi-asserted-by":"publisher","first-page":"135372","DOI":"10.1016\/j.cej.2022.135372","volume":"438","author":"W Xie","year":"2022","unstructured":"Xie W, Ye J, Guo Z, Lu J, Xu W, Gao X, et al. TME-responded full-biodegradable nanocatalyst for mitochondrial calcium overload-induced hydroxyl radical bursting cancer treatment. Chem Eng J. 2022;438:135372. https:\/\/doi.org\/10.1016\/j.cej.2022.135372.","journal-title":"Chem Eng J"},{"key":"4670_CR49","doi-asserted-by":"publisher","first-page":"156495","DOI":"10.1016\/j.apsusc.2023.156495","volume":"616","author":"P Zhang","year":"2023","unstructured":"Zhang P, Tan H, Wang Z, Lyu L, Hu C. Efficient H2O2 dissociation and formation on zinc chalcogenides: a density functional theory study. Appl Surf Sci. 2023;616:156495. https:\/\/doi.org\/10.1016\/j.apsusc.2023.156495.","journal-title":"Appl Surf Sci"},{"key":"4670_CR50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jcat.2014.03.010","volume":"313","author":"ML Kuznetsov","year":"2014","unstructured":"Kuznetsov ML, Teixeira FA, Bokach NA, Pombeiro AJL, Shul\u2019pin GB. Radical decomposition of hydrogen peroxide catalyzed by aqua complexes [M(H2O) ]2+ (M\u2009=\u2009be, Zn, Cd). J Catal. 2014;313:135\u201348. https:\/\/doi.org\/10.1016\/j.jcat.2014.03.010.","journal-title":"J Catal"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04670-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04670-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04670-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:04:51Z","timestamp":1787569491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04670-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4670"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04670-1","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were conducted in accordance with the guidelines of the Laboratory Animal Research Center in Beijing University of Chemical Technology (BUCT21-2512-086).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"800"}}